Lindbrook Capital, LLC Astrazeneca PLC Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lindbrook Capital, LLC holds 7,889 shares of AZN stock, worth $528,641. This represents 0.05% of its overall portfolio holdings.

Number of Shares

7,889

Previous 8,581 8.06%

Holding current value

$528,641

Previous $669,000 8.22%

% of portfolio

0.05%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$76.67 - $87.62 $53,055 - $60,633	-692 Reduced 8.06%	7,889 $614,000
Q2 2024 Jul 31, 2024	BUY	$66.81 - $80.83 $38,482 - $46,558	576 Added 7.2%	8,581 $669,000
Q1 2024 Apr 25, 2024	BUY	$61.03 - $69.57 $8,361 - $9,531	137 Added 1.74%	8,005 $542,000
Q4 2023 Jan 31, 2024	BUY	$61.89 - $69.28 $40,352 - $45,170	652 Added 9.04%	7,868 $529,000
Q3 2023 Oct 25, 2023	SELL	$64.85 - $71.7 $5,966 - $6,596	-92 Reduced 1.26%	7,216 $488,000
Q2 2023 Jul 28, 2023	BUY	$69.91 - $75.81 $6,851 - $7,429	98 Added 1.36%	7,308 $523,000
Q1 2023 Apr 26, 2023	BUY	$63.15 - $71.6 $38,016 - $43,103	602 Added 9.11%	7,210 $500,000
Q4 2022 Jan 24, 2023	BUY	$54.21 - $70.44 $15,178 - $19,723	280 Added 4.42%	6,608 $0
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $11,187 - $28,643	211 Added 3.45%	6,328 $347,000
Q2 2022 Aug 01, 2022	BUY	$59.26 - $71.14 $57,482 - $69,005	970 Added 18.85%	6,117 $404,000
Q1 2022 Apr 21, 2022	BUY	$55.72 - $67.12 $4,123 - $4,966	74 Added 1.46%	5,147 $341,000
Q4 2021 Jan 18, 2022	SELL	$54.02 - $63.83 $1,512 - $1,787	-28 Reduced 0.55%	5,073 $296,000
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $28,724 - $31,428	517 Added 11.28%	5,101 $306,000
Q2 2021 Jul 27, 2021	BUY	$48.42 - $60.18 $6,391 - $7,943	132 Added 2.96%	4,584 $275,000
Q1 2021 Apr 28, 2021	BUY	$47.16 - $54.44 $6,508 - $7,512	138 Added 3.2%	4,452 $221,000
Q4 2020 Jan 27, 2021	SELL	$48.52 - $58.02 $5,434 - $6,498	-112 Reduced 2.53%	4,314 $216,000
Q3 2020 Nov 03, 2020	BUY	$53.07 - $61.1 $13,267 - $15,275	250 Added 5.99%	4,426 $243,000
Q2 2020 Jul 27, 2020	BUY	$43.1 - $55.31 $21,291 - $27,323	494 Added 13.42%	4,176 $221,000
Q1 2020 Apr 22, 2020	SELL	$37.79 - $51.33 $30,458 - $41,371	-806 Reduced 17.96%	3,682 $164,000
Q4 2019 Jan 27, 2020	BUY	$42.46 - $50.46 $4,076 - $4,844	96 Added 2.19%	4,488 $224,000
Q3 2019 Oct 31, 2019	SELL	$40.12 - $45.47 $2,407 - $2,728	-60 Reduced 1.35%	4,392 $196,000
Q2 2019 Jul 24, 2019	BUY	$37.28 - $41.68 $7,120 - $7,960	191 Added 4.48%	4,452 $183,000
Q1 2019 Apr 23, 2019	SELL	$35.49 - $43.02 $993 - $1,204	-28 Reduced 0.65%	4,261 $172,000
Q4 2018 Feb 07, 2019	BUY	$36.86 - $41.49 $158,092 - $177,950	4,289 New	4,289 $162,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Astrazeneca PLC Transaction History